To evaluate the effect of the soy isoflavone genistein on the metabolic and hormonal disturbances of polycystic ovary syndrome (PCOS), we studied a group of obese, hyperinsulinemic, and dyslipidemic women presenting this syndrome during 6 months of phytoestrogen administration.
Romualdi, D., Costantini, B., Campagna, G., Lanzone, A., Guido, M., Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study, <<FERTILITY AND STERILITY>>, 2008; 90 (5): 1826-1833. [doi:10.1016/j.fertnstert.2007.09.020] [http://hdl.handle.net/10807/31763]
Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study
Romualdi, Daniela;Costantini, Barbara;Campagna, Giuseppe;Lanzone, Antonio;Guido, Maurizio
2008
Abstract
To evaluate the effect of the soy isoflavone genistein on the metabolic and hormonal disturbances of polycystic ovary syndrome (PCOS), we studied a group of obese, hyperinsulinemic, and dyslipidemic women presenting this syndrome during 6 months of phytoestrogen administration.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
